N-Myc Downstream-Regulated Gene 2 (Ndrg2) Is Involved in Ischemia–Hypoxia-Induced Astrocyte Apoptosis: a Novel Target for Stroke Therapy
- 6 May 2016
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 54 (5) , 3286-3299
Abstract
Nearly all clinical trials that have attempted to develop effective strategies against ischemic stroke have failed, excluding those for thrombolysis, and most of these trials focused only on preventing neuronal loss. However, astrocytes have gradually become a target for neuroprotection in stroke. In previous studies, we showed that the newly identified molecular N-myc downstream-regulated gene 2 (Ndrg2) is specifically expressed in astrocytes in the brain and involved in some neurodegenerative diseases. However, the role of NDRG2 in ischemic stroke remained unclear. In this study, we investigated the role of NDRG2 in middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia and in oxygen–glucose deprivation (OGD)-induced cellular apoptosis in the M1800 astrocyte cell line. NDRG2 mRNA and protein expression began to increase at 6 and 2 h after reperfusion and peaked at 24 h in the ischemic penumbra and in M1800 cells, as detected by RT-PCR and Western blotting. Double immunofluorescence staining showed that the number of apoptotic cells increased as the NDRG2-positive signal increased and that the NDRG2 signal was sometimes co-localized with TUNEL-positive cells and translocated from the cytoplasm to the nucleus in both the ischemic penumbra and the M1800 cells. Using a lentivirus, we successfully constructed two stable astrocytic cell lines in which NDRG2 expression was significantly up- or down-regulated. NDRG2 silencing had a proliferative effect and reduced the percentage of apoptotic cells, reactive oxygen species (ROS) production, and cleaved Caspase-3 protein expression following OGD, whereas NDRG2 over-expression had the opposite effects. In conclusion, NDRG2 is involved in astrocyte apoptosis following ischemic–hypoxic injury, and inhibiting NDRG2 expression significantly reduces ROS production and astrocyte apoptosis. These findings provide insight into the role of NDRG2 in ischemic–hypoxic injury and provide potential targets for future clinical therapies for stroke.Keywords
Funding Information
- National Natural Science Foundation of China (CN) (81371446)
- Natural Science Foundation of China (81403451, 81370194)
- China Postdoctoral Science Foundation (2014M562560, 2015T81110)
- Beijing Natural Science Foundation (7154242)
This publication has 36 references indexed in Scilit:
- Inhibition of N-myc Downstream–regulated Gene-2 Is Involved in an Astrocyte-specific Neuroprotection Induced by Sevoflurane PreconditioningAnesthesiology, 2014
- NDRG2 as a marker protein for brain astrocytesCell and tissue research, 2014
- Neuroprotective effects of carnosic acid on neuronal cells under ischemic and hypoxic stressNutritional Neuroscience, 2012
- Astrocytes: Targets for Neuroprotection in StrokeCentral Nervous System Agents in Medicinal Chemistry, 2011
- Spatial–temporal expression of NDRG2 in rat brain after focal cerebral ischemia and reperfusionBrain Research, 2011
- Thrombolysis With PlasminStroke, 2010
- Tripartite synapses: astrocytes process and control synaptic informationTrends in Neurosciences, 2009
- N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosisNucleic Acids Research, 2008
- Astrocyte glycogen and brain energy metabolismGlia, 2007
- Characterization of Rat NDRG2 (N-Myc Downstream Regulated Gene 2), a Novel Early Mineralocorticoid-specific Induced GeneJournal of Biological Chemistry, 2002